Biocon Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19".
Biocon Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19".